
We have some strange terms in the pharma industry, one that new entrants find most difficult to grasp is that of suspected unexpected serious adverse reactions – SUSARs. The term refers to an adverse event that occurs in a clinical trial subject, which is assessed by the sponsor and or study investigator as being unexpected, serious and as having a reasonable possibility of a causal relationship with the study drug. That’s a mouthful – yes?
It's not just the pharmaceutical industry that uses obscure terms. On February 12, 2002 (12 years ago today), Donald Rumsfeld gave a response to a question at a US Department of Defense news briefing, about the lack of evidence linking the government of Iraq with the supply of weapons of mass destruction. Rumsfeld stated:
“Reports that say that something hasn't happened are always interesting to me, because as we know, there are known knowns; there are things we know we know. We also know there are known unknowns; that is to say, we know there are some things we do not know. But there are also unknown unknowns – the ones we don't know we don't know. And if one looks throughout the history of our country and other free countries, it is the latter category that tends to be the difficult ones.”
Rumsfeld, was effectively warning that in any situation there can be known knowns and unknown unknowns, with the latter potentially being the most dangerous as they represent "things that we don't know we don't know." Interestingly, what appears to be missing from his list is the unknown knowns, the things we know, but we aren’t necessarily aware of. In the case of the English language, this understanding can make the difference between whether (or not) you will be recognised as a native English speaker (or writer). In many cases, a ‘native’ may not even remember learning this knack, and yet they will use it every day. This represents a medical writing superpower in a world hungry for native English-speaking authors.
Ordering adjectives
Believe it or not, the superpower is little more than knowing about the correct order in which to use adjectives when we write. The skill is described beautifully in the 2013 book ‘The Elements of Eloquence: How to Turn the Perfect English Phrase,’ by Mark Forsyth [1]. The book, which explains classical rhetoric, dedicates chapters to rhetorical figures with illustrating examples, particularly in the works of William Shakespeare. Regarding adjectives, Forsyth states:
“…adjectives in English absolutely have to be in this order: opinion-size-age-shape-colour-origin-material-purpose Noun. So, you can have a lovely little old rectangular green French silver whittling knife. But if you mess with that word order in the slightest, you’ll sound like a maniac. It’s an odd thing that every English speaker uses that list, but almost none of us could write it out.”
In other words, the order of adjectives has to be: opinion-size age-shape-colour-origin-material-purpose. Change this order in any way and you give away your non-English roots. And yet, most English people would not be able to tell what they are doing.
Whereas most English speakers have little interest in the practice of correct grammar, French and German speakers are a lot more interested in the mechanics of their languages – they'll argue about grammar and go and get Le Bon Usage to settle a dispute [2]. Nevertheless, there are a lot of rules like this that we don't know. We're lucky that, as native speakers, we can just open our mouths and it comes out. Whether it's the odd rules about the order of adjectives or ablaut reduplication, or the bits of etymology that are utterly obvious once you point them out. As Mark Forsyth says "there’s a reason there may be little green men on Mars, but there certainly aren’t green little men” [1]. As with any rule, there are always exceptions, but these are simply obeying another commonly unknown rule of English usage – that of ablaut reduplication.
Criss-crossing
There may not be that many opportunities to demonstrate your understanding of ablaut reduplication in your scientific writing, but it is certainly a sacred rule of language that immediately identifies non-native speakers when not followed. Why this should be is a subject of endless debate among linguists. Whether it’s something to do with the movement of our tongues or an ancient language of the Caucasus, native speakers follow the rule religiously even if they don’t know they know it. You would immediately balk at writing ‘zag-zig’ or ‘cross-criss.’ Effectively, reduplication in linguistics is when you repeat a word, sometimes with an altered consonant (i.e., nitty-gritty), and sometimes with an altered vowel (i.e., clip-clop or ding-dong). When talking vowels, if there are two words then the first uses the letter ‘i’ and the second is either ‘a’ or ‘o’ (i.e., tip top, chit-chat or tick-tock). If there are three words then the order must go ‘i’, ‘a’, ‘o’ (i.e., bish-bash-bosh).
Getting tense
Even experienced and accomplished native English speaking medical writers are adept at employing the many tenses available tenses available to them – though almost certainly not all of them will be able to name the rules they are following. Depending on how you name them there are about 20 – believe it or not. For example, understanding how to deploy the pluperfect progressive passive for an extended state of action that happened (to you) prior to another action in the past is, sounds complex. But you might happily say “I realised I’d been being watched.” These twists in how to create a flowing narrative in your writing can be daunting for those learning English. You could try explaining how English don’t usually use the present tense for things that are happening in the present. For example, “I tie my shoelaces” doesn’t mean that you’re doing it right now, it just means that this is something that you do. In contrast, we use the present progressive “I’m tying my shoelaces” when describing things we are currently doing. English gets particularly tricky when using the future present tense and even trickier when you learn that there are also exceptions, like the verb ‘to think’ used as an auxiliary. In such cases a native speaker might say “I think you’re right” whereas a non-native speaker might use the phrase “I am thinking that you are right”. It can take a lifetime of immersion learning to reach this level of expertise.
Clearly, English is a complicated language, and even native speakers often have no idea of its strangeness. A few examples are summarised here – don’t even get me started phrasal verbs and how they too can be a nightmare for would-be English speakers. Whatever the extent of your understanding, it makes a good case for using native English-speaking writers (like we have at Niche) when preparing your regulatory documents.
References


16th May 2023
- Tim Hardman
Scientific knowledge should be accessible to all and if you are those communicating science
22nd January 2019
- Tim Hardman
28th August 2018
- Tim Hardman
28th March 2025
- Tim Hardman
1st October 2018
- Tim Hardman
8th January 2017
- Tim Hardman
Searching the literature can take various forms, ranging from a quick scan of recent publications
1st April 2019
- Tim Hardman
19th November 2018
- Tim Hardman
The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)
29th March 2021
- Tim Hardman
14th March 2017
- Tim Hardman
31st October 2021
- Tim Hardman
In the past, Halloween has meant the end of the crop and the start of the dark, cold winter.
2nd June 2015
- Tim Hardman
19th October 2018
- Tim Hardman
2nd November 2023
- Tim Hardman
14th February 2024
- Tim Hardman
We recently encouraged writers (of all kinds) in our recent Insider’s Insight to experiment with large language.
27th January 2023
- Tim Hardman
Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.
19th June 2018
- Tim Hardman
Experience at Niche has taught us that clinical study protocols are born in the white-hot fire
18th April 2019
- Tim Hardman
9th May 2017
- Tim Hardman
7th July 2013
- Tim Hardman
15th August 2017
- Tim Hardman
15th February 2018
- Tim Hardman
9th February 2021
- Tim Hardman
4th April 2023
- Tim Hardman
3rd July 2019
- Tim Hardman
26th August 2015
- Tim Hardman
23rd May 2023
- Tim Hardman
I have never been great at conferences. People don’t believe me but I am painfully shy and far too worried about what.
18th May 2023
- Tim Hardman
Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,
31st January 2017
- Tim Hardman
30th March 2017
- Tim Hardman
14th April 2012
- Tim Hardman
20th June 2022
- Tim Hardman
I am continually reminded that I must work toward better relationships with my sons than the one I had with my dad.
1st July 2019
- Tim Hardman
9th August 2016
- Tim Hardman
11th May 2018
- Tim Hardman
Our team are exploring different and novel ways for young people to enter the pharmaceutical industry.
2nd January 2017
- Tim Hardman
Did you miss our Insider's Insight into understanding the complex world of bibliometrics [1]?
7th July 2016
- Tim Hardman
4th May 2018
- Tim Hardman
17th January 2018
- Tim Hardman
4th July 2018
- Tim Hardman
9th January 2016
- Tim Hardman
20th April 2016
- Tim Hardman
25th October 2019
- Tim Hardman
14th August 2018
- Tim Hardman
The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations
5th August 2019
- Tim Hardman
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
24th March 2025
- Tim Hardman
5th April 2017
- Tim Hardman
24th August 2016
- Tim Hardman
6th January 2023
- Tim Hardman
30th April 2018
- Tim Hardman
4th August 2021
- Tim Hardman
Since 2013 we have been sharing our understanding on key issues with friends and clients via our Insider’s Insights.
21st December 2018
- Tim Hardman
9th May 2017
- Tim Hardman
7th October 2012
- Tim Hardman
20th September 2016
- Tim Hardman
3rd August 2014
- Tim Hardman
8th April 2019
- Tim Hardman
31st May 2023
- Tim Hardman
Advisory board meetings are often used to address perceived knowledge gaps and build consensus.
19th May 2023
- Tim Hardman
16th June 2018
- Tim Hardman
11th September 2015
- Tim Hardman
1st August 2012
- Tim Hardman
24th February 2020
- Tim Hardman
Finding the best vehicle in which to publish your research findings is a perennial challenge.
20th April 2023
- Tim Hardman
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
16th April 2018
- Tim Hardman
4th June 2020
- Tim Hardman
15th April 2013
- Tim Hardman
11th November 2015
- Tim Hardman
15th April 2019
- Tim Hardman
25th April 2019
- Tim Hardman
2nd September 2015
- Tim Hardman
19th October 2018
- Tim Hardman
31st January 2020
- Tim Hardman
We all need heroes - people who can champion our cause - helping the world to understand our rationale
6th September 2018
- Tim Hardman
11th September 2018
- Tim Hardman
4th February 2014
- Tim Hardman
27th February 2019
- Tim Hardman
15th September 2015
- Tim Hardman
12th May 2020
- Tim Hardman
12th July 2022
- Tim Hardman
4th May 2020
- Tim Hardman
17th July 2017
- Tim Hardman
4th January 2019
- Tim Hardman
14th February 2022
- Tim Hardman
29th March 2019
- Tim Hardman
3rd March 2015
- Tim Hardman
27th January 2023
- Tim Hardman
The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,
13th December 2018
- Tim Hardman
25th February 2021
- Tim Hardman
9th October 2017
- Tim Hardman
Get our latest news and publications
Sign up to our news letterResources
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
Regular Updates

